INTECH Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
INTECH Investment Management's PFE Position: Q2 2026 in Review
INTECH Investment Management increased its Pfizer (PFE) stake by 99% in Q2 2026, buying an estimated $3.51M and bringing the position to 270,453 shares worth $6.51M. The position accounts for 0.06% of the portfolio, ranked #272.
INTECH Investment Management first reported a position in PFE in Q2 2022 and has held it in 17 quarters since. The position peaked at $68.7M in Q4 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- INTECH Investment Management held 270,453 shares of Pfizer worth $6.51M as of Q2 2026.
- INTECH Investment Management bought 134,222 Pfizer shares in Q2 2026, an estimated $3.51M.
- Pfizer made up 0.06% of INTECH Investment Management's portfolio in Q2 2026, its #272 holding.
- INTECH Investment Management first reported a position in Pfizer in Q2 2022 and has held it in 17 quarters since.
- INTECH Investment Management's Pfizer position peaked at $68.7M in Q4 2022.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.